Bullish
$ACAD 5.45 p.m LATE BREAKING COMMUNICATIONS Chairs: Jeffrey Cummings, Mike Weiner 5.45 p.m LB1 - HARMONY relapse-prevention study: pimavanserin significantly prolongs time to relapse of dementia-related psychosis Erin FOFF (1), Jeffrey CUMMINGS (2), Maria SOTO-MARTIN (3), Bradley MCEVOY (1), Srdjan STANKOVIC (1) (1) ACADIA Pharmaceuticals Inc., United States, (2) Cleveland Clinic Lou Ruvo Center for Brain Health, United States, (3) Gerontopole Alzheimer Clinical Research Center/University Hospital of Toulouse, France
  • 1
  • 2